Immunotoxins and Antibody-Drug Conjugates for Cancer Treatment
- 1 January 2002
- book chapter
- Published by Springer Nature
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Pharmacokinetics of Gemtuzumab Ozogamicin, an Antibody‐Targeted Chemotherapy Agent for the Treatment of Patients with Acute Myeloid Leukemia in First RelapseThe Journal of Clinical Pharmacology, 2001
- Targeted delivery of chemotherapeutics: tumor-activated prodrug therapyAdvanced Drug Delivery Reviews, 1998
- Syntheses and Structure−Activity Relationships of Taxoids Derived from 14β-Hydroxy-10-deacetylbaccatin IIIJournal of Medicinal Chemistry, 1997
- Immunotoxins in the therapy of cancer: From bench to clinicPharmacology & Therapeutics, 1994
- Cure of Xenografted Human Carcinomas by BR96-Doxorubicin ImmunoconjugatesScience, 1993
- The linkage of cytotoxic drugs to monoclonal antibodies for the treatment of cancerBioconjugate Chemistry, 1990
- Cytotoxicity of gelonin and its conjugates with antibodies is determined by the extent of their endocytosisJournal of Cellular Physiology, 1989
- MaytansineCancer Treatment Reviews, 1978
- One molecule of diphtheria toxin fragment a introduced into a cell can kill the cellCell, 1978
- Insulin degradation XXIII. Distribution of glutathione-insulin transhydrogenase in isolated rat hepatocytes as studied by immuno-ferritin and electron microscopyBiochimica et Biophysica Acta (BBA) - General Subjects, 1978